GLP-1 medications in New York (2026)
Coverage, telehealth, compounding, and platform availability
- 0.0%
- New York adult obesity rate
- Limited coverage
- New York Medicaid weight-loss coverage
- Permitted
- Interstate telehealth
- Winding down
- Compounding 2026
New York Medicaid and insurance coverage
New York Medicaid covers Wegovy for BMI ≥35 with comorbidity after prior authorization. Step therapy through lifestyle program required.
Commercial insurance coverage of GLP-1s in New York typically requires prior authorization. Most plans cover Ozempic and Mounjaro for documented type 2 diabetes (the easier coverage path). Wegovy and Zepbound for weight loss require BMI documentation, often ≥30 with comorbidity. Use our insurance coverage tool to check your specific plan.
Telehealth prescribing in New York
New York permits interstate telehealth with state-licensed clinicians. Required to follow standard NY medical board rules.
Top US telehealth platforms with active New York availability: Ro Body, Hims Weight Loss, Calibrate. Each handles insurance and prescribing differently — see our platform comparisons for details on which fits New York patients best.
Compounding pharmacy status (2026)
New York Board of Pharmacy has actively enforced FDA 2026 guidance; routine compounded semaglutide for weight loss is being shut down.
The national context: FDA proposed permanently ending 503B bulk compounding of semaglutide and tirzepatide on April 30, 2026, with a public comment period through June 29. Most state pharmacy boards are aligning enforcement. Patients currently on compounded GLP-1s in New York should plan transition to branded direct-pay or insurance-covered options. See our guide on the compounding shutdown.
GLP-1 in New York — frequently asked
Does New York Medicaid cover Wegovy or Zepbound for weight loss?+
Limited coverage. New York Medicaid covers Wegovy for BMI ≥35 with comorbidity after prior authorization. Step therapy through lifestyle program required. Confirm coverage with your specific plan's formulary before assuming approval. For commercial insurance in New York, coverage typically requires prior authorization with BMI documentation.
Can I get Wegovy or Ozempic via telehealth in New York?+
Permitted. New York permits interstate telehealth with state-licensed clinicians. Required to follow standard NY medical board rules. Most major US telehealth platforms — including Ro Body, Hims Weight Loss, Calibrate — operate in New York with state-licensed clinicians.
Is compounded semaglutide still legal in New York?+
Winding down. New York Board of Pharmacy has actively enforced FDA 2026 guidance; routine compounded semaglutide for weight loss is being shut down. The FDA proposed permanently ending 503B bulk compounding of semaglutide and tirzepatide on April 30, 2026. State boards of pharmacy implement enforcement at varying paces.
Which telehealth platforms operate in New York?+
Major platforms with broad New York availability include Ro Body, Hims Weight Loss, Calibrate. Coverage by program varies — some prescribe branded Wegovy and Zepbound only, others bundle telehealth with compounded preparations where still permitted.
What's the cheapest way to get Wegovy in New York?+
Three main paths: (1) insurance with prior authorization if your plan covers Wegovy (likely $0-$25 copay), (2) NovoCare manufacturer self-pay at $499/month for eligible cash patients, (3) telehealth programs that may bundle branded Wegovy with clinical visits. Direct-to-consumer manufacturer programs typically beat retail pharmacy prices.